First Time Loading...

Shanghai MicroPort Endovascular MedTech Group Co Ltd
SSE:688016

Watchlist Manager
Shanghai MicroPort Endovascular MedTech Group Co Ltd Logo
Shanghai MicroPort Endovascular MedTech Group Co Ltd
SSE:688016
Watchlist
Price: 185.44 CNY 6.04% Market Closed
Updated: Apr 29, 2024

Wall Street
Price Targets

Price Targets Summary
Shanghai MicroPort Endovascular MedTech Group Co Ltd

Wall Street analysts forecast Shanghai MicroPort Endovascular MedTech Group Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Shanghai MicroPort Endovascular MedTech Group Co Ltd is 241.77 CNY with a low forecast of 232.3 CNY and a high forecast of 264.74 CNY.

Lowest
Price Target
232.3 CNY
25% Upside
Average
Price Target
241.77 CNY
30% Upside
Highest
Price Target
264.74 CNY
43% Upside
Shanghai MicroPort Endovascular MedTech Group Co Ltd Competitors:
Price Targets
ALC
Alcon AG
18% Upside
119610
Interojo Co Ltd
80% Upside
COLO B
Coloplast A/S
9% Upside
603658
Autobio Diagnostics Co Ltd
12% Upside
7730
Mani Inc
38% Upside
MMSI
Merit Medical Systems Inc
29% Upside
688029
Micro-Tech Nanjing Co Ltd
45% Upside
137310
SD Biosensor Inc
59% Upside

Revenue
Forecast

Revenue Estimate
Shanghai MicroPort Endovascular MedTech Group Co Ltd

For the last 6 years the compound annual growth rate for Shanghai MicroPort Endovascular MedTech Group Co Ltd's revenue is 39%. The projected CAGR for the next 3 years is 29%.

39%
Past Growth
29%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Shanghai MicroPort Endovascular MedTech Group Co Ltd

For the last 6 years the compound annual growth rate for Shanghai MicroPort Endovascular MedTech Group Co Ltd's operating income is 40%. The projected CAGR for the next 3 years is 29%.

40%
Past Growth
29%
Estimated Growth
Estimates Accuracy
0%
Average Beat

Net Income
Forecast

Net Income Estimate
Shanghai MicroPort Endovascular MedTech Group Co Ltd

For the last 6 years the compound annual growth rate for Shanghai MicroPort Endovascular MedTech Group Co Ltd's net income is 41%. The projected CAGR for the next 3 years is 30%.

41%
Past Growth
30%
Estimated Growth
Estimates Accuracy
-11%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Shanghai MicroPort Endovascular MedTech Group Co Ltd's stock price target?
Price Target
241.77 CNY

According to Wall Street analysts, the average 1-year price target for Shanghai MicroPort Endovascular MedTech Group Co Ltd is 241.77 CNY with a low forecast of 232.3 CNY and a high forecast of 264.74 CNY.

What is Shanghai MicroPort Endovascular MedTech Group Co Ltd's Revenue forecast?
Projected CAGR
29%

For the last 6 years the compound annual growth rate for Shanghai MicroPort Endovascular MedTech Group Co Ltd's revenue is 39%. The projected CAGR for the next 3 years is 29%.

What is Shanghai MicroPort Endovascular MedTech Group Co Ltd's Operating Income forecast?
Projected CAGR
29%

For the last 6 years the compound annual growth rate for Shanghai MicroPort Endovascular MedTech Group Co Ltd's operating income is 40%. The projected CAGR for the next 3 years is 29%.

What is Shanghai MicroPort Endovascular MedTech Group Co Ltd's Net Income forecast?
Projected CAGR
30%

For the last 6 years the compound annual growth rate for Shanghai MicroPort Endovascular MedTech Group Co Ltd's net income is 41%. The projected CAGR for the next 3 years is 30%.